Ardelyx (ARDX) Cash from Investing Activities (2013 - 2026)
Ardelyx posted quarterly Cash from Investing Activities of -$10.0 million for Q1 2026, down 450.58% year-on-year from $2.9 million in Q1 2025, and down 364.7% on a QoQ basis from $3.8 million in Q4 2025.
Ardelyx (ARDX) has 14 years of Cash from Investing Activities data on file, last reported at -$10.0 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 450.58% year-over-year to -$10.0 million; the trailing twelve-month figure through Mar 2026 stood at -$21.8 million (down 69.1% YoY), and the FY2025 full-year result was -$9.0 million, up 51.09% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$10.0 million, down from $3.8 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $34.9 million in Q2 2025 and bottomed at -$59.2 million in Q2 2023.
- The 5-year median for Cash from Investing Activities is -$832000.0 (2022), against an average of -$8.8 million.
- The widest annual swing landed in 2023, when Cash from Investing Activities sank 3829.93%; it then jumped 210.85% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at $1.4 million in 2022, then sank by 2151.84% to -$29.6 million in 2023, then plunged by 40.77% to -$41.6 million in 2024, then soared by 109.07% to $3.8 million in 2025, then sank by 364.7% to -$10.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$10.0 million (Q1 2026), $3.8 million (Q4 2025), and -$50.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -10.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.00 Mn |
| Mar 31, 2026 | -10.00 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | -50.51 Mn |
| Sep 30, 2025 | -50.51 Mn |
| Jun 30, 2025 | 34.92 Mn |
| Jun 30, 2025 | 34.92 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | -41.62 Mn |
| Dec 31, 2024 | -41.62 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Jun 30, 2024 | 23.53 Mn |
| Mar 31, 2024 | -2.57 Mn |
| Mar 31, 2024 | -2.57 Mn |
| Dec 31, 2023 | -29.57 Mn |
| Dec 31, 2023 | -29.57 Mn |
| Sep 30, 2023 | -32.70 Mn |
| Sep 30, 2023 | -32.70 Mn |
| Jun 30, 2023 | -59.21 Mn |
| Jun 30, 2023 | -59.21 Mn |
| Mar 31, 2023 | -9.78 Mn |
| Mar 31, 2023 | -9.78 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Sep 30, 2022 | -832,000.00 |
| Sep 30, 2022 | -832,000.00 |
| Jun 30, 2022 | 15.47 Mn |
| Jun 30, 2022 | 15.47 Mn |
| Mar 31, 2022 | 2.33 Mn |
| Mar 31, 2022 | 2.33 Mn |
| Dec 31, 2021 | 22.10 Mn |
| Dec 31, 2021 | 22.10 Mn |
| Sep 30, 2021 | 18.13 Mn |
| Sep 30, 2021 | 18.13 Mn |
| Jun 30, 2021 | 8.23 Mn |
| Jun 30, 2021 | 8.23 Mn |
| Mar 31, 2021 | 2.49 Mn |
| Mar 31, 2021 | 2.49 Mn |
| Dec 31, 2020 | -3.57 Mn |
| Dec 31, 2020 | -3.57 Mn |
| Sep 30, 2020 | 9.59 Mn |
| Sep 30, 2020 | 9.59 Mn |
| Jun 30, 2020 | 13.42 Mn |
| Jun 30, 2020 | 13.42 Mn |
| Mar 31, 2020 | -50.88 Mn |
| Mar 31, 2020 | -50.88 Mn |
| Dec 31, 2019 | -55.46 Mn |
| Dec 31, 2019 | -55.46 Mn |
| Sep 30, 2019 | 23.45 Mn |
| Sep 30, 2019 | 23.45 Mn |
| Jun 30, 2019 | 25.41 Mn |
| Jun 30, 2019 | 25.41 Mn |
| Mar 31, 2019 | 29.98 Mn |
| Mar 31, 2019 | 29.98 Mn |
| Dec 31, 2018 | 22.19 Mn |
| Dec 31, 2018 | 22.19 Mn |
| Sep 30, 2018 | 10.09 Mn |
| Sep 30, 2018 | 10.09 Mn |
| Jun 30, 2018 | -61.04 Mn |
| Jun 30, 2018 | -61.04 Mn |
| Mar 31, 2018 | -1.14 Mn |
| Mar 31, 2018 | -1.14 Mn |
| Dec 31, 2017 | 11.22 Mn |
| Dec 31, 2017 | 11.22 Mn |
| Sep 30, 2017 | 14.81 Mn |
| Sep 30, 2017 | 14.81 Mn |
| Jun 30, 2017 | 16.29 Mn |
| Jun 30, 2017 | 16.29 Mn |
| Mar 31, 2017 | 22.97 Mn |
| Mar 31, 2017 | 22.97 Mn |
| Dec 31, 2016 | -59.23 Mn |
| Dec 31, 2016 | -59.23 Mn |
| Sep 30, 2016 | -71.35 Mn |
| Sep 30, 2016 | -71.35 Mn |
| Jun 30, 2016 | -295,000.00 |
| Jun 30, 2016 | -295,000.00 |
| Mar 31, 2016 | -200,000.00 |
| Mar 31, 2016 | -200,000.00 |
| Dec 31, 2015 | -454,000.00 |
| Dec 31, 2015 | -454,000.00 |
| Sep 30, 2015 | -680,000.00 |
| Sep 30, 2015 | -680,000.00 |
| Jun 30, 2015 | -1.27 Mn |
| Jun 30, 2015 | -1.27 Mn |
| Mar 31, 2015 | -1.06 Mn |
| Mar 31, 2015 | -1.06 Mn |
| Dec 31, 2014 | -1.03 Mn |
| Dec 31, 2014 | -1.03 Mn |
| Sep 30, 2014 | -88,000.00 |
| Sep 30, 2014 | -88,000.00 |
| Jun 30, 2014 | -642,000.00 |
| Jun 30, 2014 | -642,000.00 |
| Mar 31, 2014 | -94,000.00 |
| Mar 31, 2014 | -94,000.00 |
| Sep 30, 2013 | -21,000.00 |
| Sep 30, 2013 | -21,000.00 |